Loading... (0%)
About liver disease

The International Liver Congress™ 2015

Date: April 22-26, 2015

Location: Vienna - Austria

GENFIT will host an analyst and investor event in conjunction with the EASL 50th Annual Meeting (The International Liver Congress 2015) on Friday, April 24th at 12:00pm in Vienna.

During the event, management and key opinion leaders will discuss more detailed results from the Phase 2b study of GFT505 in NASH as well as the next steps forward including plans for Phase 3. In addition, Prof. Philippe Lehert, will provide an overview on the statistical analysis plan used in the Phase 2b study.

During the workshop, in addition to management, confirmed KOLs present will be:
  • Vlad Ratziu, MD, PhD - Principal Investigator and International Coordinator of the GOLDEN-505 study
  • Philippe Lehert, MD, PhD - UN Senior Consulting Statistician, Faculty of Medicine, University of Melbourne, Australia - Faculty of Economics, UCL Mons, Louvain, Belgium
  • Bart Staels, PhD - Member of the Institut Universitaire de France, Inserm UMR1011 & UDSL, Université Lille Nord de France, Institut Pasteur de Lille
To RSVP for the event, or for more information, please contact Danny Matthews (dmatthews@troutgroup.com / +1 646-378-2928).

More information on EASL congress: http://www.easl.eu

Save this event:

Export Ical 0
elementum Sed dolor vulputate, sed Curabitur Praesent Nullam accumsan